Gregory T. Chesnut

Supplementary Table S2 shows gene expression evaluated as a continuous variable and by median and Youden index cutoffs for BCR-free and metastasis-free survival.

Supplementary Table S3 shows Total TILs and individual cell type vs TILs scores evaluated as a continuous variable and by median and Youden index cutoffs for BCR-free and metastasis-free survival.

Supplementary Figure S8 shows non-significant relative cell type scores by Dx Age Group.

Supplementary Figure S4 shows non-significant relative cell type scores by GG.

Significant relative cell type scores for clinicopathologic variables. Relative cell type scores that demonstrated significance for GG (A), Gleason sum (B), metastasis (C), age at diagnosis group (D), and PSA (E) at diagnosis group are shown. Mann–Whitney U test (A, C) or Kruskal–Wallis test followed by Dunn multiple comparisons post-hoc test (B, D, E) were used to determine significance, as indicated by listed P values below 0.05. Each dot represents a patient score, and error bars correspond to mean ± SD.

TABLE 1 from Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression

Supplementary Figure S2 shows non-significant relative cell type scores by race.

Supplementary Figure S6 shows non-significant relative cell type scores by Gleason Sum.

Supplementary Figure S11 shows BCR-free and Metastasis-free survival for cell types dichotomized by median cutoffs.

Supplementary Figure S5 shows non-significant relative cell type scores by metastasis status.